(secondQuint)Copaxone Subcutaneous Injection Syringe Special Drug Use-Result Investigation (All-Case Investigation) "Prevention of Relapse of Multiple Sclerosis".

 The drug being tested in this study is called Glatiramer acetate is being tested to treat people who have Multiple sclerosis.

 This study will look at the safety and efficacy of Glatiramer acetate in patients with multiple sclerosis in the routine clinical setting.

 The study will enroll approximately 1000 patients.

 cent Glatiramer acetate subcutaneous injection syringe This multi-center trial will be conducted in Japan.

.

 Copaxone Subcutaneous Injection Syringe Special Drug Use-Result Investigation (All-Case Investigation) "Prevention of Relapse of Multiple Sclerosis"@highlight

The purpose of this study is to evaluate the safety and efficacy of Copaxone subcutaneous injection syringe (hereinafter referred to as Copaxone) in patients with multiple sclerosis in the routine clinical setting.

